Gain Therapeutics (GANX) Other Gross PP&E Adjustments (2020 - 2025)
Gain Therapeutics (GANX) has 6 years of Other Gross PP&E Adjustments data on record, last reported at -$230095.0 in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 470.81% year-over-year to -$230095.0; the TTM value through Sep 2025 reached -$230095.0, down 470.81%, while the annual FY2024 figure was -$454705.0, 28.9% up from the prior year.
- Other Gross PP&E Adjustments reached -$230095.0 in Q3 2025 per GANX's latest filing, up from -$400220.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$40310.0 in Q3 2024 and bottomed at -$1.0 million in Q4 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$461751.9, with a median of -$427993.0 recorded in 2021.
- Peak YoY movement for Other Gross PP&E Adjustments: soared 85.83% in 2024, then crashed 470.81% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.0 million in 2021, then skyrocketed by 30.35% to -$705062.0 in 2022, then grew by 9.3% to -$639490.0 in 2023, then rose by 28.9% to -$454705.0 in 2024, then surged by 49.4% to -$230095.0 in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$230095.0 in Q3 2025, -$400220.0 in Q2 2025, and -$220617.0 in Q1 2025.